Dosimetric quantification of the incidental irradiation of the ‘true’ (deep) ano-inguinal lymphatic drainage of anal cancer patients not described in conventional contouring guidelines

6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Introduction: The ano-inguinal lymphatic drainage (AILD) is located in the subcutaneous adipose tissue of the proximal medial thigh. Findings from fluorescence methods give us new information about anatomical conditions of the AILD. Current contouring guidelines do not advise the inclusion of the ‘true’ AILD into the clinical target volume (CTV). Aim of this work was the retrospective analysis of the incidental dose to the AILD in an anal cancer (AC) patient cohort who underwent definitive chemoradiation (CRT) therapy with Volumetric Arc Therapy–Intensity Modulated Radiation Therapy (VMAT-IMRT). Methods: VMAT-IMRT plans of 15 AC patients were analyzed. Based on findings from new fluorescence methods we created a new volume, the expected AILD. The examined dosimetric parameters were the minimal, maximal and mean dose and V10–V50 that were delivered to the AILD, respectively. Results: The median volume of AILD was 1047 cm³. Mean Dmin, Dmax and Dmean were 7.5 Gy, 58.9 Gy and 40.8 Gy for AILD. The clinical relevant dose of 30.0 Gray covered in mean 76% of the volume of the AILD, respectively. Conclusions: Only 76% of the AILD-volume received at least an expected required treatment dose of 30 Gy incidentally. Concerning the low number of loco-regional relapses in AC patients after definitive CRT one has to balance increased side effects against a rigid oncological–anatomical interpretation of the local lymphatic drainage by including the AILD into the standard CTV.

References Powered by Scopus

Use of Normal Tissue Complication Probability Models in the Clinic

1388Citations
N/AReaders
Get full text

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial

725Citations
N/AReaders
Get full text

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): A randomised, phase 3, open-label, 2×2 factorial trial

581Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Patterns of recurrence in anal cancer: A detailed analysis

28Citations
N/AReaders
Get full text

Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines

21Citations
N/AReaders
Get full text

Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer

6Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Dapper, H., Habl, G., Hirche, C., Münch, S., Oechsner, M., Mayinger, M., … Habermehl, D. (2018). Dosimetric quantification of the incidental irradiation of the ‘true’ (deep) ano-inguinal lymphatic drainage of anal cancer patients not described in conventional contouring guidelines. Acta Oncologica, 57(6), 825–830. https://doi.org/10.1080/0284186X.2017.1415459

Readers over time

‘18‘19‘20‘21‘22‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

88%

Researcher 1

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

80%

Biochemistry, Genetics and Molecular Bi... 1

10%

Sports and Recreations 1

10%

Save time finding and organizing research with Mendeley

Sign up for free
0